- Home
- LMNR vs BDTX Comparison
LMNR vs BDTX Comparison
Compare LMNR & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMNR
- BDTX
- Stock Information
- Founded
- LMNR 1893
- BDTX 2014
- Country
- LMNR United States
- BDTX United States
- Employees
- LMNR N/A
- BDTX N/A
- Industry
- LMNR Farming/Seeds/Milling
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LMNR Consumer Staples
- BDTX Health Care
- Exchange
- LMNR Nasdaq
- BDTX Nasdaq
- Market Cap
- LMNR 264.6M
- BDTX 220.3M
- IPO Year
- LMNR N/A
- BDTX 2020
- Fundamental
- Price
- LMNR $13.41
- BDTX $4.50
- Analyst Decision
- LMNR Buy
- BDTX Strong Buy
- Analyst Count
- LMNR 2
- BDTX 5
- Target Price
- LMNR $20.50
- BDTX $10.40
- AVG Volume (30 Days)
- LMNR 60.9K
- BDTX 911.1K
- Earning Date
- LMNR 12-22-2025
- BDTX 11-06-2025
- Dividend Yield
- LMNR 2.24%
- BDTX N/A
- EPS Growth
- LMNR N/A
- BDTX N/A
- EPS
- LMNR N/A
- BDTX 0.38
- Revenue
- LMNR $160,763,000.00
- BDTX $70,000,000.00
- Revenue This Year
- LMNR N/A
- BDTX N/A
- Revenue Next Year
- LMNR N/A
- BDTX N/A
- P/E Ratio
- LMNR N/A
- BDTX $11.88
- Revenue Growth
- LMNR N/A
- BDTX N/A
- 52 Week Low
- LMNR $13.25
- BDTX $1.20
- 52 Week High
- LMNR $28.41
- BDTX $4.94
- Technical
- Relative Strength Index (RSI)
- LMNR 33.26
- BDTX 59.65
- Support Level
- LMNR $13.25
- BDTX $3.79
- Resistance Level
- LMNR $14.05
- BDTX $4.94
- Average True Range (ATR)
- LMNR 0.38
- BDTX 0.29
- MACD
- LMNR -0.04
- BDTX 0.07
- Stochastic Oscillator
- LMNR 13.59
- BDTX 64.39
About LMNR Limoneira Co
Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.